Showing results (481-490 of 9,003) with videos related to

Sort By:
Pageof 901
European Journal of Clinical Pharmacology|January 1, 1990
Hemodynamic profile of carvedilolV Hombach, M Kochs, M Höher, et al.
European Journal of Clinical Pharmacology|January 1, 1990
Effects of carvedilol on common carotid arterial flow, peripheral hemodynamics, and hemorheologic variables in hypertensionY Nagakawa, Y Akedo, S Kaku, et al.
European Journal of Clinical Pharmacology|January 1, 1990
Effects of carvedilol on serum lipids in hypertensive and normotensive subjectsH Seguchi, H Nakamura, N Aosaki, et al.
European Journal of Clinical Pharmacology|January 1, 1990
Efficacy and safety of carvedilol in renal hypertension. A multicenter open trialT Takeda, M Kohno, M Ishii, et al.
European Journal of Clinical Pharmacology|January 1, 1990
Safety and efficacy of once-daily carvedilol vs twice-daily labetalol in mild to moderate hypertensionJ P Ollivier, P Durier, J L Bussiere, et al.
European Journal of Clinical Pharmacology|January 11, 1990
The pharmacology of carvedilolR R Ruffolo, M Gellai, J P Hieble, et al.
European Journal of Clinical Pharmacology|January 1, 1990
Effects of carvedilol on renal functionA G Dupont
European Journal of Clinical Pharmacology|August 12, 2009
Clinical and pharmacogenetic determinants for the discontinuation of non-ergoline dopamine agonists in Parkinson's diseaseMaurits E L Arbouw, Kris L L Movig, Toine C G Egberts, et al.
European Journal of Clinical Pharmacology|August 27, 2009
Montelukast use during pregnancy: a multicentre, prospective, comparative study of infant outcomesMoumita Sarkar, Gideon Koren, Sanjog Kalra, et al.
European Journal of Clinical Pharmacology|January 1, 1990
DOPA decarboxylase inhibition does not influence the diuretic and natriuretic response to exogenous alpha-atrial natriuretic peptide in manS Kageyama, J Brown, R Causon, et al.
Pageof 901